Coloplast A/S - Coloplast completes the acquisition of Kerecis - Invitation for conference call on Monday, 4 September 2023 at 14.00-15.00 CEST
Werte in diesem Artikel
Monday, 4 September 2023 at 14.00 – 15.00 CEST
In connection with the completion of the acquisition of Kerecis, Coloplast will host a conference call with Fertram Sigurjonsson, Founder and CEO of Kerecis.
A presentation will be available on Coloplast’s website before the conference call.
The webcast of the conference call will be available during and after the event.
Coloplast will be represented by:
Kristian Villumsen - President & CEO
Anders Lonning-Skovgaard - Executive Vice President, CFO
Fertram Sigurjonsson - Founder and CEO of Kerecis
Aleksandra Dimovska - Senior Director, Investor Relations
Kristine Husted Munk - Senior Manager, Investor Relations
Webcast
Any participants who do not wish to actively participate in the question & answer session, please access the conference call as a webcast directly by clicking here:
Access the webcast
Dial-in details
For analysts and any participants wishing to actively participate in the question & answer session please sign up ahead of the conference call on the link below to receive an email with dial-in details:
Register here
For more information, please contact:
Aleksandra Dimovska - Senior Director, IR. Tel.: +45 4911 1800 / direct: +45 4911 2458. E-mail: dkadim@coloplast.com
Kristine Husted Munk - Senior Manager, IR. Tel.: +45 4911 1800 / direct: +45 4911 3266. E-mail: dkkhu@coloplast.com
Hannah K. Larsen - Coordinator & PA, IR. Tel.: +45 4911 1800 / direct: +45 4911 3616. E-mail: dkhakl@coloplast.com
Coloplast will be available on individual phone lines after the conference call for further questions.
Attachment
Ausgewählte Hebelprodukte auf Coloplast A-S (B)
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Coloplast A-S (B)
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Coloplast A-S (B) Aktie News
Coloplast A-S (B) Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Coloplast A-S (B) nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.12.12 | Coloplast equal-weight | Morgan Stanley | |
| 04.07.12 | Coloplast neutral | J.P. Morgan Cazenove | |
| 15.03.12 | Coloplast sell | UBS AG | |
| 07.12.11 | Coloplast buy | Société Générale Group S.A. (SG) |